Bottom Line
- *Fair warning: this is our longest video yet, about 20 minutes. It walks through every common testosterone treatment option, the tradeoffs, and the honest risks, so you can find the one that fits your life and your goals. Watch the full guide below:
The Key Takeaways
There is no single best option. You match the route to your goal: fertility, convenience, cost, or steady levels. Every option carries risk, so monitoring is what keeps you safe.
Not everyone is a candidate. A real candidate has clear symptoms (especially sexual), two low morning readings, reversible causes fixed first, and a monitoring plan.
Want to keep your fertility? Do not start testosterone. Testosterone therapy reduces sperm production and the size of the testicles. Clomiphene or hCG raise your own production instead, and that conversation has to happen before you start.
The TRAVERSE trial did not say what people think. In more than 5,000 high-risk men, a normal-dose gel showed no rise in heart attacks or strokes (Lincoff et al., N Engl J Med 2023). It did not say high doses are safe, or that you can skip monitoring.
For most men, TRT is a lifelong commitment. Start it and your own production shuts down. Coming off is hard, and for some men close to impossible.
The options, side by side
Same goal, very different tradeoffs. Here is the honest comparison.
Option | Pros | Cons |
|---|---|---|
Gel (daily) | Steady levels, easy to fine-tune the dose | Can rub off on others, skin irritation |
Patch (nightly) | Mimics your natural rhythm, almost no transfer | More skin irritation |
Oral pill (twice daily) | No needles, no transfer to others | Can raise blood pressure, lab timing matters |
Injection (weekly or microdosed) | Cheap, flexible, very effective | Peaks and troughs unless microdosed, self-injection |
Pellets (every 3 to 6 months) | Set and forget, steady, about 90% satisfied | Minor procedure, fixed dose you cannot adjust, tapers near the end |
Clomiphene or hCG (daily) | Preserves fertility, boosts your own production | Off-label, not right for everyone |
A few honest notes the table cannot hold: “bio-identical” is mostly marketing, since nearly all FDA-approved testosterone already is bioidentical. And pushing testosterone to sustained levels above the normal range (>900) can be dangerous and may cause: thicker blood, more estrogen, and strain on the heart and kidneys.
Bottom Line
Treat the man, not the number. Low testosterone is often a marker of something upstream, so fix the fixable causes first.
Pick for your goal. Fertility points to clomiphene or hCG; convenience to gels or pellets; cost and control to microdosed injections.
Whatever you choose, get monitored. Red blood cells, PSA, estrogen, and blood pressure can all drift. Regular labs are the price of doing this safely.
Know the commitment. For most men this is lifelong, so be sure you want it before you start.
You almost certainly know a man weighing whether to start testosterone, or already on it without much monitoring. Please forward this to him. It is the honest, complete picture he needs.
Catch up on the series
Part 3, Treatment Options: this issue and video
References
Lincoff et al., N Engl J Med 2023 (TRAVERSE) · Mulhall et al., AUA Guideline, J Urol 2018 · Bhasin et al., Endocrine Society, J Clin Endocrinol Metab 2018 · FDA Prescribing Information: Jatenzo, Tlando, Kyzatrex, Xyosted, Aveed